PTC TherapeuticsPTCT
那斯達克 · USD
75.44
+1.34
(+1.81%)
收盤 12/12 04:59 (UTC+8)
盤後
76.81
+1.37
(+1.82%)
12/12 04:59 (UTC+8)
PTC TherapeuticsPTCT
75.44
+1.34
(+1.81%)
財務數據
損益表
- 2.14
- 1.97
- 3.07
- 2.10
- 1.87
- 1.97
- 2.13
- 11.76
- 1.79
- 2.11
- -2.98
- -8.06
- 56.20
- -31.57
- -11.14
- 5.40
- 8.33
- 451.71
- -84.79
- 17.96
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 211,007 | 178,875 | 1,176,096 | 213,172 | 196,786 | 186,704 | 210,118 | 307,056 | 196,576 | 213,808 |
營業成本 | 23,315 | 15,481 | 16,660 | 19,590 | 13,884 | 18,392 | 66,270 | 106,292 | 68,142 | 60,128 |
營業毛利 | 187,692 | 163,394 | 1,159,436 | 193,582 | 182,902 | 168,312 | 143,848 | 200,764 | 128,434 | 153,680 |
營業費用 | 184,676 | 198,351 | 189,211 | 355,971 | 237,412 | 208,530 | - | 194,944 | 246,598 | 363,223 |
研發費用 | 100,158 | 112,990 | 108,973 | 124,770 | 161,412 | 132,169 | 116,129 | 121,353 | 164,212 | 185,874 |
推銷及管理費用 | 84,046 | 85,262 | 80,161 | 74,508 | 74,156 | 74,600 | 73,172 | 73,591 | 82,386 | -40,451 |
非經常性項目費用 | 472 | 99 | 77 | 156,693 | 1,844 | 1,761 | - | - | - | 217,800 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 3,016 | -34,957 | 970,225 | -162,389 | -54,510 | -40,218 | -45,453 | 5,820 | -118,164 | -209,543 |
其他收入及費用 | 6,502 | -5,737 | -6,305 | 108,750 | -1,872 | -2,025 | 1,591 | -118,596 | -20,266 | 1,478 |
利息費用 | 32,592 | 30,358 | 34,092 | 41,060 | 41,609 | 43,490 | 40,834 | 44,275 | 28,160 | 29,414 |
稅前純益 | -23,074 | -71,052 | 929,828 | -94,699 | -97,991 | -85,733 | -84,696 | -157,051 | -166,590 | -237,479 |
所得稅 | -38,970 | -6,203 | 63,266 | -28,813 | 8,663 | 13,446 | 6,880 | -1,259 | -33,620 | -38,596 |
稅後純益 | 15,896 | -64,849 | 866,562 | -65,886 | -106,654 | -99,179 | -91,576 | -155,792 | -132,970 | -198,883 |
基本每股稅後盈餘(元) | 0.20 | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | - | -1.76 | -2.66 |
稀釋每股稅後盈餘(元) | 0.20 | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.67 |
基本平均股數(千股) | 78471.00 | 78151.00 | 78115.00 | 77201.00 | 76925.00 | 76725.00 | 76496.00 | - | 75377.00 | 74730.00 |
稀釋平均股數(千股) | 87115.00 | 78151.00 | 86385.00 | 77201.00 | 76925.00 | 76725.00 | 76496.00 | - | 75377.00 | 74730.00 |
還原基本每股稅後盈餘(元) | 0.20 | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | - | -1.76 | -2.66 |
還原稀釋每股稅後盈餘(元) | 0.20 | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.67 |
還原基本平均股數(千股) | 78,471 | 78,151 | 78,115 | 77,201 | 76,925 | 76,725 | 76,496 | - | 75,377 | 74,730 |
還原稀釋平均股數(千股) | 87,115 | 78,151 | 86,385 | 77,201 | 76,925 | 76,725 | 76,496 | - | 75,377 | 74,730 |
EBITDA(千元) | 14,829 | -37,365 | 969,127 | -49,150 | -52,550 | -38,226 | 8,132 | -33,883 | -75,803 | -156,500 |